U.S. Trade Chief Meets Pfizer, AstraZeneca About Vaccine Supply

April 27, 2021, 1:39 AM UTC

U.S. trade chief Katherine Tai met with key officials at Pfizer Inc. and AstraZeneca Plc about raising production of Covid-19 vaccines and a proposed waiver of intellectual-property protections as the daily number of confirmed cases keeps rising.

Tai met virtually with Ruud Dobber, the executive vice-president of AstraZeneca’s biopharmaceuticals business unit, and separately with Pfizer Chairman and Chief Executive Officer Albert Bourla, the office of the U.S. Trade Representative said in statements Monday.

Katherine Tai
Photographer: Bill O’Leary/The Washington Post/Bloomberg

India and South Africa have proposed that the World Trade Organization waive broad sections of the its intellectual-property rules and to try to forge an ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.